Ovid Therapeutics Inc.·4

Feb 26, 6:03 PM ET

Rona Jeffrey A 4

4 · Ovid Therapeutics Inc. · Filed Feb 26, 2024

Insider Transaction Report

Form 4
Period: 2024-02-22
Transactions
  • Award

    Common Stock

    2024-02-22+28,12528,125 total
  • Award

    Stock Option (Right to Buy)

    2024-02-22+168,7500 total
    Exercise: $3.68Exp: 2034-02-21Common Stock (168,750 underlying)
Footnotes (3)
  • [F1]Represents a restricted stock unit (RSU) award. One-third (1/3) of the total number of RSUs shall vest on January 1, 2025 and one-third (1/3) of the remaining RSUs shall vest each year thereafter on anniversary of the vesting commencement date, subject to the Reporting Person's continuous service through such vesting date.
  • [F2]Each RSU represents a contingent right to receive one share of Common Stock.
  • [F3]25% of the shares subject to the Stock Option will vest and become exercisable on February 22, 2025 and the remaining shares will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued services through such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION